1 |
Uniform data set language measures for bvFTD and PPA diagnosis and monitoring.
|
|
|
|
In: Alzheimer's & dementia (Amsterdam, Netherlands), vol 13, iss 1 (2021)
|
|
BASE
|
|
Show details
|
|
2 |
Uniform data set language measures for bvFTD and PPA diagnosis and monitoring.
|
|
|
|
In: Alzheimer's & dementia (Amsterdam, Netherlands), vol 13, iss 1 (2021)
|
|
BASE
|
|
Show details
|
|
3 |
German Language Adaptation of the NAVS (NAVS-G) and of the NAT (NAT-G): Testing Grammar in Aphasia
|
|
|
|
In: Brain Sci (2021)
|
|
BASE
|
|
Show details
|
|
4 |
Uniform data set language measures for bvFTD and PPA diagnosis and monitoring
|
|
|
|
In: Alzheimers Dement (Amst) (2021)
|
|
BASE
|
|
Show details
|
|
5 |
German language adaptation of the NAVS (NAVS-G) and of the NAT (NAT-G): testing grammar in aphasia
|
|
|
|
In: Brain sciences. - 11, 4 (2021) , 474, ISSN: 2076-3425 (2021)
|
|
BASE
|
|
Show details
|
|
6 |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.
|
|
|
|
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
|
|
BASE
|
|
Show details
|
|
7 |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.
|
|
|
|
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
|
|
BASE
|
|
Show details
|
|
8 |
Data from: ApoE is a correlate of phenotypic heterogeneity in Alzheimer’s disease in a national cohort ...
|
|
|
|
BASE
|
|
Show details
|
|
9 |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
|
|
|
|
In: Alzheimers Dement (2020)
|
|
BASE
|
|
Show details
|
|
10 |
APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort
|
|
Weintraub, Sandra; Teylan, Merilee; Rader, Benjamin; Chan, Kwun C.G.; Bollenbeck, Mark; Kukull, Walter A.; Coventry, Christina; Rogalski, Emily; Bigio, Eileen; Mesulam, M.-Marsel
|
|
In: Neurology (2020)
|
|
Abstract:
OBJECTIVE: To compare the proportion of APOE ε4 genotype carriers in aphasic vs amnestic variants of Alzheimer disease (AD). METHOD: The proportion of APOE ε4 carriers was compared among the following 3 groups: (1) 42 patients with primary progressive aphasia (PPA) and AD pathology (PPA/AD) enrolled in the Northwestern Alzheimer Disease Center Clinical Core; (2) 1,418 patients with autopsy-confirmed AD and amnestic dementia of the Alzheimer type (DAT/AD); and (3) 2,608 cognitively normal controls (NC). The latter 2 groups were compiled from the National Alzheimer Coordinating Center database. Logistic regression models analyzed the relationship between groups and APOE ε4 carrier status, adjusting for age at onset and sex as needed. RESULTS: Using NC as the reference and adjusting for sex and age, the DAT/AD group was 3.97 times more likely to be APOE ε4 carriers. Adjusting for sex and age at symptom onset, the DAT/AD group was 2.46 times as likely to be carriers compared to PPA/AD. There was no significant difference in the proportion of APOE ε4 carriers for PPA/AD compared to NC. PPA subtypes included 24 logopenic, 10 agrammatic nonfluent, and 8 either mixed (n = 5) or too severe (n = 3) to subtype. The proportion of carriers and noncarriers was similar for logopenic and agrammatic subtypes, both having fewer carriers. CONCLUSION: The proportion of APOE ε4 carriers was elevated in amnestic but not aphasic manifestations of AD. These results suggest that APOE ε4 is an anatomically selective risk factor that preferentially increases the vulnerability to AD pathology of memory-related medial temporal areas rather than language-related neocortices.
|
|
Keyword:
Article
|
|
URL: http://www.ncbi.nlm.nih.gov/pubmed/31704790 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136069/ https://doi.org/10.1212/WNL.0000000000008666
|
|
BASE
|
|
Hide details
|
|
11 |
Measurement and characterization of distinctive clinical phenotypes using the Frontotemporal Lobar Degeneration Module (FTLD-MOD)
|
|
|
|
In: Alzheimers Dement (2020)
|
|
BASE
|
|
Show details
|
|
12 |
Familial language network vulnerability in primary progressive aphasia
|
|
|
|
In: Neurology (2020)
|
|
BASE
|
|
Show details
|
|
13 |
Montreal Cognitive Assessment (MoCA) Performance and Domain-Specific Index Scores in Amnestic versus Aphasic Dementia
|
|
|
|
In: J Int Neuropsychol Soc (2020)
|
|
BASE
|
|
Show details
|
|
14 |
Genetic screen in a large series of patients with primary progressive aphasia
|
|
|
|
BASE
|
|
Show details
|
|
15 |
PREFERENTIAL DISRUPTION OF AUDITORY WORD REPRESENTATIONS IN PRIMARY PROGRESSIVE APHASIA WITH THE NEUROPATHOLOGY OF FTLD-TDP TYPE A
|
|
|
|
BASE
|
|
Show details
|
|
16 |
Northwestern Anagram Test-Italian (Nat-I) for primary progressive aphasia
|
|
|
|
In: Cortex (2019)
|
|
BASE
|
|
Show details
|
|
17 |
Clinical and cortical decline in the aphasic variant of Alzheimer’s disease
|
|
|
|
BASE
|
|
Show details
|
|
18 |
Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer’s disease
|
|
|
|
In: Brain Pathol (2019)
|
|
BASE
|
|
Show details
|
|
19 |
Word comprehension in temporal cortex and Wernicke area: A PPA perspective
|
|
|
|
BASE
|
|
Show details
|
|
20 |
Morphology and Distribution of TDP-43 Pre-inclusions in Primary Progressive Aphasia
|
|
|
|
BASE
|
|
Show details
|
|
|
|